Evaluation of Pharmacokinetics and Safety of A006 in Healthy Volunteers

Condition:   Asthma
Interventions:   Drug: A006 DPI;   Drug: A006 DPI;   Drug: Proventil® MDI;   Drug: Proventil® MDI
Sponsor:   Amphastar Pharmaceuticals, Inc.
Active, not recruiting – verified October 2014

View full post on ClinicalTrials.gov: asthma | received in the last 14 days